Related references
Note: Only part of the references are listed.Biomarkers of Targeted Therapy and Immuno-Oncology in Cancers Metastatic to the Breast
Semir Vranic et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Antibody-Drug Conjugates: A Comprehensive Review
Puregmaa Khongorzul et al.
MOLECULAR CANCER RESEARCH (2020)
Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers
Semir Vranic et al.
CLINICAL BREAST CANCER (2020)
NTRKfusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma
Joseph T. Rabban et al.
HISTOPATHOLOGY (2020)
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour -agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T. Yoshino et al.
ANNALS OF ONCOLOGY (2020)
Delta-like Protein 3 Expression and Targeting in Merkel Cell Carcinoma
Hao Xie et al.
ONCOLOGIST (2020)
Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast
Semir Vranic et al.
CLINICAL BREAST CANCER (2019)
Molecular characterization of cancers with NTRK gene fusions
Zoran Gatalica et al.
MODERN PATHOLOGY (2019)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C. Marchio et al.
ANNALS OF ONCOLOGY (2019)
The PTEN-PI3K Axis in Cancer
Antonella Papa et al.
BIOMOLECULES (2019)
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
Daniel Morgensztern et al.
CLINICAL CANCER RESEARCH (2019)
Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors
Hao Xie et al.
LUNG CANCER (2019)
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
Stacey M. Gargano et al.
CANCER MEDICINE (2019)
A clinical analysis of small-cell neuroendocrine carcinoma of the gynecologic tract: report of 20 cases
Yue He et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
NTRK-1 fusion in endocervical fibroblastic malignant peripheral nerve sheath tumor marking eligibility for larotrectinib therapy: A case report
A. E. Wells et al.
GYNECOLOGIC ONCOLOGY REPORTS (2019)
Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix
Deyin Xing et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Clemens B. Tempfer et al.
BMC CANCER (2018)
Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy
Zoran Gatalica et al.
EUROPEAN JOURNAL OF CANCER (2018)
Small cell cancers of the female genital tract: Molecular and clinical aspects
Jay R. Patibandla et al.
GYNECOLOGIC ONCOLOGY (2018)
A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix
Philip E. Castle et al.
GYNECOLOGIC ONCOLOGY (2018)
Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients
Ari Vanderwalde et al.
CANCER MEDICINE (2018)
Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors
Darren S. Sigal et al.
Oncotarget (2018)
Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases
Maria Alejo et al.
PAPILLOMAVIRUS RESEARCH (2018)
Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists
Angiolo Gadducci et al.
GYNECOLOGIC ONCOLOGY (2017)
Activity of Entrectinib in a Patient With the First Reported NTRK Fusion in Neuroendocrine Cancer
Darren Sigal et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center
Andrew Sharabi et al.
ONCOLOGIST (2017)
Patterns of recurrence and survival in neuroendocrine cervical cancer
Shane R. Stecklein et al.
GYNECOLOGIC ONCOLOGY (2016)
Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer
Michael Frumovitz et al.
GYNECOLOGIC ONCOLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
Andrea Casadei Gardini et al.
PLOS ONE (2014)
Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation
Yasmin A. Lyons et al.
GYNECOLOGIC ONCOLOGY REPORTS (2014)
High Frequency of Activating PIK3CA Mutations in Human Papillomavirus-Positive Oropharyngeal Cancer
Anthony C. Nichols et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)
Share Paper
